Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458520 · ClinicalTrials.gov registry record
Pediatric PET/MR Image Registry
A clinical trial of Lymphoma and Osteosarcoma, sponsored by Stanford University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03458520 is a study of Lymphoma and Osteosarcoma that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03458520, a study of Lymphoma and Osteosarcoma, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PET/CT imaging
- DIAGNOSTIC_TEST PET/MR imaging
- DIAGNOSTIC_TEST MR imaging
Study Locations (1)
California
- Stanford University, School of Medicine - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03458520
The ClinicalTrials.gov registry entry for NCT03458520 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (79% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which PET/CT imaging is the first listed.
NCT03458520 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03458520 about?
NCT03458520 is a clinical study titled "Pediatric PET/MR Image Registry". The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic ...
What is the current status of trial NCT03458520?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-02-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03458520 study?
This clinical trial studies the following conditions: Lymphoma, Osteosarcoma, Soft Tissue.
What interventions are being tested in trial NCT03458520?
The interventions under investigation include: PET/CT imaging (DIAGNOSTIC_TEST), PET/MR imaging (DIAGNOSTIC_TEST), MR imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03458520?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03458520 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.